Actively Recruiting
Observational Study of Spectral Precise Image Quality in Adults with Diagnosed Brain Tumors Using Spectral CT 7500
Led by Philips Clinical & Medical Affairs Global · Updated on 2026-06-02
120
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the image quality and diagnostic confidence of Spectral Precise Image reconstruction technology using spectral CT scans in patients with confirmed brain tumors. This observational study aims to explore how well this technology performs in imaging brain tumors, focusing on both subjective and objective measures of image quality. The study is sponsored by Philips Clinical & Medical Affairs Global and will provide insights into this imaging method for patients aged 18 years and older. Participants will undergo contrast-enhanced scans using the Spectral CT 7500 device. This study collects observational data without altering the usual care or introducing new treatments. The study period for image evaluation is anticipated to last about three months from the date of image reconstruction until the completion of image reading. During the study, participants images will be assessed for quality using a Likert score and objective measures. No additional interventions are administered beyond the imaging procedure, and the study involves reviewing clinical and radiological data. Participation involves consenting to the use of their imaging data for analysis. The total duration of participation corresponds to the imaging and evaluation timeline, with safety and usual care maintained throughout.
CONDITIONS
Brief Title
Spectral Precise Image Study for Brain Tumors
Research Team
J
Jing Wang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here